Paired Tumor/Normal - Comprehensive Hematologic Cancer Panel
GTR Test Accession: Help GTR000596303.2
CANCERPHARMACOGENOMIC
Last updated in GTR: 2023-11-30
Last annual review date for the lab: 2023-09-29 LinkOut
At a Glance
Diagnosis; Drug Response; Monitoring; ...
Hematologic neoplasm; Thiopurine response
ABL1 (9q34.12), ABL2 (1q25.2), AKT3 (1q43-44), ALK (2p23.2-23.1), ARHGAP26 (5q31.3), ...
Molecular Genetics - Deletion/duplication analysis: Next-Generation (NGS)/Massively parallel sequencing (MPS); ...
Not provided
Not provided
Not provided
Ordering Information
Offered by: Help
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics
View lab's website
View lab's test page
Specimen Source: Help
  • Bone marrow
  • Cell culture
  • Cord blood
  • Fibroblasts
  • Fresh tissue
  • Frozen tissue
  • Isolated DNA
  • Paraffin block
  • Peripheral (whole) blood
  • Skin
  • View specimen requirements
Test Order Code: Help
COHMC
CPT codes: Help
**AMA CPT codes notice
Lab contact: Help
DGD GeneticCounselor, Genetic Counselor
DGDGeneticCounselor@chop.edu
How to Order: Help
Each specimen must be accompanied by a physician's test request. Informed consent is desirable. Proper billing information should also be provided on the test requisition form.
Order URL
Test development: Help
Test developed by laboratory (no manufacturer test name)
Informed consent required: Help
Decline to answer
Pre-test genetic counseling required: Help
Decline to answer
Post-test genetic counseling required: Help
Decline to answer
Recommended fields not provided:
Conditions Help
Total conditions: 2
Condition/Phenotype Identifier
Test Targets
Genes Help
Total genes: 215
Gene Associated Condition Germline or Somatic Allele (Lab-provided) Variant in NCBI
Methodology
Total methods: 3
Method Category Help
Test method Help
Instrument *
Deletion/duplication analysis
Next-Generation (NGS)/Massively parallel sequencing (MPS)
RNA analysis
Next-Generation (NGS)/Massively parallel sequencing (MPS)
Sequence analysis of the entire coding region
Next-Generation (NGS)/Massively parallel sequencing (MPS)
* Instrument: Not provided
Clinical Information
Test purpose: Help
Diagnosis; Drug Response; Monitoring; Prognostic; Therapeutic management
Recommended fields not provided:
Technical Information
Availability: Help
Tests performed
Entire test performed in-house
Analytical Validity: Help
Analytical sensitivity= 100% Analytical specificity = >99% NOTE: For copy number variants, the validation samples mostly consisted of CNVs encompassing >7 exon CNVs (though we do report CNVs detected that are 3 exons or larger).
Proficiency testing (PT):
Is proficiency testing performed for this test? Help
No
Recommended fields not provided:
Regulatory Approval
FDA Review: Help
Category: FDA exercises enforcement discretion
Additional Information

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.